title: Should HIV testing week be blood-borne-virus testing week?
authors.affiliation: Department of Infection and Immunity, Royal London Hospital, Whitechapel, London, UK. Electronic address: chloe.orkin@bartshealth.nhs.uk.
authors.forename: Chloe
authors.initials: C
authors.lastname: Orkin
authors.affiliation: Department of Infection and Immunity, Royal London Hospital, Whitechapel, London, UK.
authors.forename: Emma
authors.initials: E
authors.lastname: Wallis
mesh_terms: D017848:Blood-Borne Pathogens / Q000302:isolation & purification*; D064790:Clinical Laboratory Services; D005060:Europe / Q000453:epidemiology; D015658:HIV Infections / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening / Q000639:trends; D011159:Population Surveillance / Q000379:methods*; D011237:Predictive Value of Tests; D015995:Prevalence; D012680:Sensitivity and Specificity; D016036:Seroepidemiologic Studies